Kura Oncology Inc KURA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:21 AM EDT
22.81quote price arrow down-0.56 (-2.40%)
Volume
141,049
52 week range
15.49 - 43.00

...

Loading . . .
  • Open23.34
  • Day High23.65
  • Day Low22.75
  • Prev Close23.37
  • 52 Week High43.00
  • 52 Week High Date12/09/20
  • 52 Week Low15.49
  • 52 Week Low Date06/15/20

Key Stats

  • Market Cap1.512B
  • Shares Out66.27M
  • 10 Day Average Volume0.60M
  • Dividend-
  • Dividend Yield-
  • Beta1.91
  • YTD % Change-29.58

KEY STATS

  • Open23.34
  • Day High23.65
  • Day Low22.75
  • Prev Close23.37
  • 52 Week High43.00
  • 52 Week High Date12/09/20
  • 52 Week Low15.49
  • 52 Week Low Date06/15/20
  • Market Cap1.512B
  • Shares Out66.27M
  • 10 Day Average Volume0.60M
  • Dividend-
  • Dividend Yield-
  • Beta1.91
  • YTD % Change-29.58

RATIOS/PROFITABILITY

  • EPS (TTM)-1.73
  • P/E (TTM)-13.21
  • Fwd P/E (NTM)-11.04
  • EBITDA (MRQ)-102.293M
  • ROE (MRQ)-25.62%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)1.11%

EVENTS

  • Earnings Date08/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kura Oncology Inc

There is no recent news for this security.

Profile

MORE
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Its segment is engaged in the discovery and development of personalized therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small molecule product candidates that targets cell-signaling pathways, which drives the progression of...
Troy Wilson J.D., Ph.D.
Chairman
Kathleen Ford
Chief Operating Officer
Marc Grasso M.D.
Chief Financial Officer
Address
12730 HIGH BLUFF DRIVE, SUITE 400
San Diego, CA
92130
United States

Top Peers

SYMBOLLASTCHG%CHG
GBIO
Generation Bio Co
28.15+0.26+0.92%
KRYS
Krystal Biotech Inc
64.09-0.66-1.02%
CRTX
Cortexyme Inc
47.79+0.24+0.49%
REPL
Replimune Group Inc
33.55-1.12-3.23%
STOK
Stoke Therapeutics Inc
36.64-2.02-5.22%